MedTrace Logo

The Use of Metformin in Early Breast Cancer Patients Pre-Surgery

NCT01302002 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL

Last updated 2016-02-23

No results posted yet for this study

Summary

The study will test metformin in patients with early breast cancer. Blood and tissue will be collected before and after the use of metformin.

Conditions

Interventions

DRUG

Metformin Pre-Surgery

500 mg tablet, taken twice a day for 3 weeks

Sponsors & Collaborators

  • Instituto Nacional de Cancer, Brazil

    lead OTHER_GOV

Principal Investigators

  • Ana Elisa Lohmann, MD · Instituto Nacional de Cancer

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01302002 on ClinicalTrials.gov